Compound 1515
Identifiers
- Canonical SMILES:
Fc1ccc(cc1)-n1[nH]c2c3cnn(Cc4ccccc4)c3nc(-c3cccc(c3)C(F)(F)F)c2c1=O
- InChi:
InChI=1S/C27H17F4N5O/c28-19-9-11-20(12-10-19)36-26(37)22-23(17-7-4-8-18(13-17)27(29,30)31)33-25-21(24(22)34-36)14-32-35(25)15-16-5-2-1-3-6-16/h1-14,34H,15H2
- InChiKey:
SGHKYMCDSXFGCM-UHFFFAOYSA-N
External links
![]() 168317960 |
External search
|
|
|
|
|
Bibliography (1)
Pharmacological data
| Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|
| 1 | 0 | 0 | 0 |
Targets
| PPI family | Best activity | Diseases | MMoA |
|---|---|---|---|
| CD80 / CD28 | 7.15 | cancer | Inhibition |
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 503.14 g/mol | |||
| HBA | 6 | |||
| HBD | 1 | |||
| HBA + HBD | 7 | |||
| AlogP | 6.86 | |||
| TPSA | 63.05 | |||
| RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
| Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 |
| Ta | Structure | Name | Drugbank ID |
|---|---|---|---|
| 0.5234 | Riociguat | DB08931 | |
| 0.5112 | ATX-914 | DB12673 | |
| 0.5062 | Vericiguat | DB15456 | |
| 0.4855 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
| 0.4828 | Tepotinib | DB15133 | |
| 0.4789 | MK-0249 | DB11910 | |
| 0.4721 | Dilmapimod | DB12140 | |
| 0.4629 | CVT-6883 | DB05936 | |
| 0.4591 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08534 | |
| 0.4585 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
| 0.4546 | Rilematovir | DB15672 | |
| 0.4538 | Risdiplam | DB15305 | |
| 0.4487 | Ravoxertinib | DB15281 | |
| 0.4438 | Methaqualone | DB04833 | |
| 0.4353 | Decoglurant | DB11923 |




